1038 related articles for article (PubMed ID: 19296494)
1. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
2. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO
Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
[TBL] [Abstract][Full Text] [Related]
4. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular staging for the severity of chronic rhinosinusitis.
Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil infiltration and activation in nasal polyposis.
Fan GK; Wang H; Takenaka H
Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
[TBL] [Abstract][Full Text] [Related]
9. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
Seto H; Suzaki H; Shioda S
Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis.
Ding GQ; Zheng CQ; Bagga SS
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1097-103. PubMed ID: 18025312
[TBL] [Abstract][Full Text] [Related]
12. Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps.
Schaefer D; Meyer JE; Pods R; Pethe W; Hedderich J; Schmidt C; Maune S
Int Arch Allergy Immunol; 2006; 140(3):205-14. PubMed ID: 16682802
[TBL] [Abstract][Full Text] [Related]
13. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps.
Seiberling KA; Conley DB; Tripathi A; Grammer LC; Shuh L; Haines GK; Schleimer R; Kern RC
Laryngoscope; 2005 Sep; 115(9):1580-5. PubMed ID: 16148698
[TBL] [Abstract][Full Text] [Related]
14. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
Front Immunol; 2019; 10():74. PubMed ID: 30778348
[No Abstract] [Full Text] [Related]
15. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bacterial examinations between eosinophilic and neutrophilic chronic rhinosinusitis with nasal polyps.
Hirotsu M; Kikuchi K; Kusunoki T; Kase K; Ono N; Ikeda K
Acta Otolaryngol; 2011 Sep; 131(9):997-1001. PubMed ID: 21612504
[TBL] [Abstract][Full Text] [Related]
17. Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients.
Paplińska M; Hermanowicz-Salamon J; Nejman-Gryz P; Białek-Gosk K; Rubinsztajn R; Arcimowicz M; Placha G; Góra J; Chazan R; Grubek-Jaworska H
Cytokine; 2012 Nov; 60(2):393-9. PubMed ID: 22846146
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
